XML 51 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2013
Dec. 31, 2012
Assets:    
Cash $ 86,824 $ 108,619
Restricted cash 15,794   
Securities available-for-sale, at estimated fair value 37,559 67,079
Securities, at estimated fair value 250,660 211,809
Commercial mortgage loans, held for investment 160,893 142,921
Subordinate loans, held for investment 394,554 246,246
Repurchase agreements, held for investment    6,598
Interest receivable 5,673 4,277
Deferred financing costs, net 794 678
Other assets    203
Total Assets 952,751 788,430
Liabilities:    
Borrowings under repurchase agreements 227,167 225,158
Investments purchased, not yet settled 21,299   
Derivative instruments, net    155
Accounts payable and accrued expenses 1,719 1,265
Payable to related party 2,656 2,037
Dividends payable 17,023 12,891
Total Liabilities 269,864 241,506
Commitments and Contingencies (see Note 13)      
Stockholders’ Equity:    
Preferred stock, $0.01 par value, 50,000,000 shares authorized and 3,450,000 shares issued and outstanding in 2013 and 2012 35 35
Common stock, $0.01 par value, 450,000,000 shares authorized, 36,883,467 and 28,044,106 shares issued and outstanding in 2013 and 2012, respectively 369 280
Additional paid-in-capital 696,337 546,065
Retained earnings (accumulated deficit) (13,235) 574
Accumulated other comprehensive loss (619) (30)
Total Stockholders’ Equity 682,887 546,924
Total Liabilities and Stockholders’ Equity $ 952,751 $ 788,430